The Focused Ultrasound Foundation and Royal Philips (NYSE: PHG, AEX: PHIA) have entered into an innovative public-private collaboration with The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust. The partnership will create a focal point for ultrasound therapy research at The Institute of Cancer Research (ICR) and The Royal Marsden in London under the international Focused Ultrasound FoundationCenters of Excellence Program.

The Medical Imaging & Technology Alliance (MITA) today applauded the American Association for Thoracic Surgery (AATS) for endorsing the United States Preventive Services Task Force’s (USPSTF) draft recommendation for annual low-dose computed tomography scans (LDCT) for individuals at high-risk of developing lung cancer.

The American Society for Radiation Oncology (ASTRO) has selected 10 distinguished members to receive the Fellow of ASTRO designation (FASTRO). The 2013 class of Fellows will receive the recognition during the Awards Ceremony on Tuesday, September 24, at ASTRO’s 55th Annual Meeting, September 22-25, 2013, at the Georgia World Congress Center in Atlanta.

Last month, a study published in The New England Journal of Medicine (NEJM) demonstrated how radium-223 could reduce the risk of death in patients with castration-resistant prostate cancer by targeting bone metastases, a common complication.

Representatives Jackie Speier (D-CA), Ways and Means Health Subcommittee Ranking Member Jim McDermott (D-WA) and Dina Titus (D-NV), recently introduced H.R. 2914, the Promoting Integrity in Medicare Act of 2013 (PIMA), in the House of Representatives.

The American Association of Clinical Urologists (AACU), the American Urological Association (AUA) and the Large Urology Group Practice Association (LUGPA), today jointly refuted the U.S. Government Accountability Office’s (GAO) flawed and misleading study on the use of intensity-modulated radiation therapy (IMRT) for the treatment of prostate cancer.

Elekta (NSE: EKTAb) and Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the Froedtert & The Medical College of Wisconsin Clinical Cancer Center (Milwaukee, Wisconsin) will join a consortium that is investigating the development of a magnetic resonance imaging (MRI) guided radiation therapy system.

Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that PillCam(R) COLON has been cleared by Japan's Pharmaceuticals & Medical Devices Agency (PMDA) for diagnosis of colonic disease when colonoscopy is required but difficult to conduct, including patients unwilling or unable to undergo colonoscopy.